Medicaid Closed Drug Formularies: A Closed Door or a Path Forward?
As we noted in July, CMS declined Massachusetts’ Medicaid 1115 demonstration request to establish a closed formulary. The proposed program would have given Massachusetts the ability to exclude certain FDA-approved drugs from coverage and thereby given the state additional leverage in negotiating rebates. The state and drug manufacturers would have otherwise continued to be subject to the rest of … Read more